Literature DB >> 2992913

Microsomal phosphorylase in rat heart: depletion following adrenalectomy and restoration by in vivo administration of dexamethasone.

N Narayanan, R L Khandelwal.   

Abstract

Phosphorylase activities were determined in homogenates, particulate and soluble fractions of heart muscle from control, adrenalectomized, and adrenalectomized dexamethasone-treated rats so as to assess the influence, if any, of glucocorticoids on the subcellular distribution of this enzyme. The specific activities (enzyme activity expressed as units per mg protein) and recoveries (enzyme activity expressed as units per fraction/g tissue) of both the active form of phosphorylase (phosphorylase a) and total phosphorylase (phosphorylases a and b) were essentially similar in homogenates and 10,000 X g particulate fractions prepared from hearts of control, adrenalectomized, and adrenalectomized dexamethasone-treated rats. Interestingly, however, the specific activities and recoveries of active as well as total phosphorylase were markedly lower (70-80%; P less than 0.001) in cardiac microsomes of adrenalectomized compared to control rats. On the other hand, the specific activities and recoveries of phosphorylase (active and total) were significantly higher (30-60%; P less than 0.01 or 0.001) in the cytosol fraction of heart muscle from adrenalectomized compared to control rats. Treatment of adrenalectomized rats with dexamethasone (a synthetic glucocorticoid) restored the specific activities and recoveries of phosphorylase in heart microsomal and cytosol fractions to control levels. No appreciable differences were observed in the specific activity ratios of phosphorylase a to phosphorylases a and b in any of the subcellular fractions of cardiac muscle from control, adrenalectomized, and adrenalectomized dexamethasone-treated rats. The above findings suggest a potential involvement of glucocorticoids in the maintenance of the membrane-associated (microsomal) pool of phosphorylase and, therefore, in the cellular compartmentalization of this enzyme in heart muscle.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2992913     DOI: 10.1210/endo-117-4-1544

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Dexamethasone treatment improves sarcoplasmic reticulum function and contractile performance in aged myocardium.

Authors:  Njanoor Narayanan; Chengxin Yang; Ande Xu
Journal:  Mol Cell Biochem       Date:  2004-11       Impact factor: 3.396

Review 2.  Reversible cardiomyopathy in a child with Addison's disease.

Authors:  M Derish; K Eckert; C Chin
Journal:  Intensive Care Med       Date:  1996-05       Impact factor: 17.440

Review 3.  The Heart of the Matter: Cardiac Manifestations of Endocrine Disease.

Authors:  Aditya John Binu; Kripa Elizabeth Cherian; Nitin Kapoor; Sujith Thomas Chacko; Oommen George; Thomas Vizhalil Paul
Journal:  Indian J Endocrinol Metab       Date:  2017 Nov-Dec

4.  Takotsubo-like syndrome triggered by fludrocortisone overdose for Addison's disease: a case report.

Authors:  Radu Campean; Matthias Hasun; Claudia Stöllberger; Johannes Bucher; Josef Finsterer; Christoph Schnack; Franz Weidinger
Journal:  J Med Case Rep       Date:  2016-10-12

Review 5.  Association of Endocrine Conditions With Takotsubo Cardiomyopathy: A Comprehensive Review.

Authors:  Sonali Gupta; Pradeep Goyal; Sana Idrees; Sourabh Aggarwal; Divyansh Bajaj; Joseph Mattana
Journal:  J Am Heart Assoc       Date:  2018-10-02       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.